Open Standard Media Player version 1.3
The U.S. government is stepping up efforts to combat Alzheimer's disease.
Tuesday, the Department of Health and Human Services set a 2025 deadline to find effective ways to treat this disease.
The HHS also unveiled a detailed blueprint of attack, including two major clinical trials.
The first involves an insulin nasal spray for treating the disease.
The second study involves a drug intended to stop symptoms in people at the highest risk for Alzheimer's.
More than five million Americans have Alzheimer's or related dementias.
That number is expected to jump to 16 million by 2050.
The government has also launched a website as a resource for people to find out more about the disease, caregiving and getting help.
A link is set up for you at www.fox 21online.com/links.
It seems like there's a pill for just about everything.
Now, researchers at Yale University say they have a drug that could help prevent people from getting drunk, thereby reducing the number of deadly drunk driving accidents.
It reportedly blocks the effects of alcohol on the central nervous system.
Meanwhile, more American adults say they have problems with sleepwalking.
Researchers at Stanford University say they found more than eight million U.S. adults experience sleepwalking.
That's about 3.6 percent of the population.
Nearly one out of three Americans say they have been caught sleepwalking at least once — usually as children.
One possible factor the study found is the use of over–the–counter sleep aids increasing the likelihood of sleepwalking in some adults.